Adipose-Derived Biocellular Therapies
Using your own healthy tissue cells to heal other parts of the body.
What are Adipose-Derived Biocellular Therapies?
Our powerful injection therapies use an adipose (fatty) tissue graft from your body which is rich in regenerative cells, including adipose-derived stem cells (ASCs). These cells can help to repair degenerative conditions in ligaments, tendons, muscles, skin, and hair. They also improve sexual health.
How does it work?
The healthy cells from the fatty tissue initiate repair of the damaged cells and provide the cellular matrices needed to repair and restore tissues. This helps your own body to orchestrate a powerful regenerative healing process that’s effective for many types of conditions.
What Conditions do Biocellular Therapies Treat?
- Degenerative osteoarthritic changes to joints (knees, hips, shoulders, ankles, wrists, and spine)
- Nonsurgical alternatives for potential total joint replacement and muscle/ligament/meniscal repairs
- Chronic joint pain and instability
- Advanced management for acute and chronic sprains, strains and other sports related injuries
- Ligament, muscle and tendon damage including meniscal tears, rotator cuff tears, calcific tendinosis, frozen shoulder, chronic tendinitis, such as tennis/golfers’ elbow, plantar fasciitis and chronic ankle instability
- Men’s health, including erectile dysfunction
- Women’s health, including vaginal regeneration
- Hair loss (for both men and women)
Adipose-Derived Biocellular Therapies FAQs
Why adipose tissue?
Adipose tissue is fat tissue that contains multiple types of healthy cells. It’s an optimal biocellular material because it offers cellular, biological and structural support for injection therapies, creates tissue scaffolding to support repair, is simple to harvest, and contains about 1,000 times as many stem cells as bone marrow.
Are there other types of adipose-derived tissue therapies?
In general, there are two basic types of adipose-derived tissue therapies for interventional orthopedic and orthobiologic medicine. The first is called Tissue Stromal Vascular Fraction (t-SVF), and that’s what we use at NW Regen. The second is called Cellular Stromal Vascular Fraction (c-SVF), which is regulated by the FDA for research.
How do we perform Tissue Stomal Vascular Fraction (t-SVF) for biocellular therapy?
Our harvesting procedure is minimally invasive, with a low-force liposuction procedure that takes about 3 hours from start to finish. We begin by drawing Platelet-Rich Plasma (PRP) for use with the t-SVF. Then we use a local anesthetic for patient comfort and harvest the adipose tissue using a sterile, closed syringe technique. Next, the sample is washed, concentrated, micro-fragmented, and emulsified in our lab to produce t-SVF, before it is injected back into the target site along with the PRP, using ultrasound for visual guidance.
What should I expect following treatment?
Most people typically experience post-treatment discomfort that resolves after several days.
What outcomes should I expect from adipose-derived biocellular therapies?
Our goal is to help reverse and prevent further degenerative processes, restore or repair aging and damaged tissues, and reduce the need for surgery. Most patients experience reduced pain and inflammation and can return to more normal life activities.